Logo image of HIPO

HIPPO HOLDINGS INC (HIPO) Stock Fundamental Analysis

USA - NYSE:HIPO - US4335392027 - Common Stock

33.59 USD
-0.28 (-0.83%)
Last: 11/10/2025, 8:04:00 PM
34.94 USD
+1.35 (+4.02%)
After Hours: 11/10/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, HIPO scores 4 out of 10 in our fundamental rating. HIPO was compared to 146 industry peers in the Insurance industry. The financial health of HIPO is average, but there are quite some concerns on its profitability. HIPO is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year HIPO was profitable.
HIPO had a positive operating cash flow in the past year.
HIPO had negative earnings in each of the past 5 years.
In the past 5 years HIPO reported 4 times negative operating cash flow.
HIPO Yearly Net Income VS EBIT VS OCF VS FCFHIPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -0.63%, HIPO is not doing good in the industry: 86.30% of the companies in the same industry are doing better.
HIPO has a Return On Equity of -3.21%. This is amonst the worse of the industry: HIPO underperforms 86.30% of its industry peers.
Industry RankSector Rank
ROA -0.63%
ROE -3.21%
ROIC N/A
ROA(3y)-13.93%
ROA(5y)-15.77%
ROE(3y)-46.66%
ROE(5y)-56.13%
ROIC(3y)N/A
ROIC(5y)N/A
HIPO Yearly ROA, ROE, ROICHIPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

HIPO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIPO Yearly Profit, Operating, Gross MarginsHIPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

6

2. Health

2.1 Basic Checks

HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
HIPO has more shares outstanding than it did 1 year ago.
HIPO has more shares outstanding than it did 5 years ago.
HIPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HIPO Yearly Shares OutstandingHIPO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HIPO Yearly Total Debt VS Total AssetsHIPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

HIPO has an Altman-Z score of -0.52. This is a bad value and indicates that HIPO is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of -0.52, HIPO is doing good in the industry, outperforming 64.38% of the companies in the same industry.
HIPO has a debt to FCF ratio of 2.62. This is a good value and a sign of high solvency as HIPO would need 2.62 years to pay back of all of its debts.
With a Debt to FCF ratio value of 2.62, HIPO perfoms like the industry average, outperforming 50.68% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that HIPO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.14, HIPO is in the better half of the industry, outperforming 73.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.62
Altman-Z -0.52
ROIC/WACCN/A
WACC8.75%
HIPO Yearly LT Debt VS Equity VS FCFHIPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.38 indicates that HIPO has no problem at all paying its short term obligations.
HIPO has a Current ratio of 3.38. This is amongst the best in the industry. HIPO outperforms 95.21% of its industry peers.
HIPO has a Quick Ratio of 3.38. This indicates that HIPO is financially healthy and has no problem in meeting its short term obligations.
HIPO has a better Quick ratio (3.38) than 95.21% of its industry peers.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.38
HIPO Yearly Current Assets VS Current LiabilitesHIPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 165.70% over the past year.
Looking at the last year, HIPO shows a very strong growth in Revenue. The Revenue has grown by 34.39%.
HIPO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.72% yearly.
EPS 1Y (TTM)165.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%662.69%
Revenue 1Y (TTM)34.39%
Revenue growth 3Y59.79%
Revenue growth 5Y60.72%
Sales Q2Q%26.28%

3.2 Future

HIPO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.34% yearly.
The Revenue is expected to grow by 18.91% on average over the next years. This is quite good.
EPS Next Y54.78%
EPS Next 2Y40.28%
EPS Next 3Y34.65%
EPS Next 5Y44.34%
Revenue Next Year26.78%
Revenue Next 2Y24.39%
Revenue Next 3Y23.33%
Revenue Next 5Y18.91%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIPO Yearly Revenue VS EstimatesHIPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
HIPO Yearly EPS VS EstimatesHIPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10

4

4. Valuation

4.1 Price/Earnings Ratio

HIPO is valuated reasonably with a Price/Earnings ratio of 9.28.
Compared to the rest of the industry, the Price/Earnings ratio of HIPO indicates a somewhat cheap valuation: HIPO is cheaper than 63.70% of the companies listed in the same industry.
HIPO is valuated cheaply when we compare the Price/Earnings ratio to 26.28, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for HIPO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 9.28
Fwd PE N/A
HIPO Price Earnings VS Forward Price EarningsHIPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIPO indicates a slightly more expensive valuation: HIPO is more expensive than 70.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 45.94
EV/EBITDA N/A
HIPO Per share dataHIPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

HIPO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIPO's earnings are expected to grow with 34.65% in the coming years.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y40.28%
EPS Next 3Y34.65%

0

5. Dividend

5.1 Amount

HIPO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HIPPO HOLDINGS INC

NYSE:HIPO (11/10/2025, 8:04:00 PM)

After market: 34.94 +1.35 (+4.02%)

33.59

-0.28 (-0.83%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-04 2026-03-04/amc
Inst Owners48.71%
Inst Owner Change-4.98%
Ins Owners9.25%
Ins Owner Change-4.62%
Market Cap840.76M
Revenue(TTM)449.80M
Net Income(TTM)-10.70M
Analysts80
Price Target41.14 (22.48%)
Short Float %3.54%
Short Ratio4.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)44.43%
Min EPS beat(2)-18.4%
Max EPS beat(2)107.26%
EPS beat(4)3
Avg EPS beat(4)200.02%
Min EPS beat(4)-18.4%
Max EPS beat(4)683.12%
EPS beat(8)6
Avg EPS beat(8)104.62%
EPS beat(12)6
Avg EPS beat(12)54.63%
EPS beat(16)6
Avg EPS beat(16)33.7%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)1.29%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)4.27%
Revenue beat(12)7
Avg Revenue beat(12)4.33%
Revenue beat(16)8
Avg Revenue beat(16)2.63%
PT rev (1m)9.01%
PT rev (3m)19.51%
EPS NQ rev (1m)-35.64%
EPS NQ rev (3m)719.05%
EPS NY rev (1m)-185.5%
EPS NY rev (3m)66.31%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-3.33%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 9.28
Fwd PE N/A
P/S 1.98
P/FCF 45.94
P/OCF 28.6
P/B 2.53
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)3.62
EY10.78%
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.73
FCFY2.18%
OCF(TTM)1.17
OCFY3.5%
SpS16.97
BVpS13.26
TBVpS10.79
PEG (NY)0.17
PEG (5Y)N/A
Graham Number32.87
Profitability
Industry RankSector Rank
ROA -0.63%
ROE -3.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 4.31%
ROA(3y)-13.93%
ROA(5y)-15.77%
ROE(3y)-46.66%
ROE(5y)-56.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.62
Debt/EBITDA N/A
Cap/Depr 47.84%
Cap/Sales 2.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.38
Quick Ratio 3.38
Altman-Z -0.52
F-Score7
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)139.06%
Cap/Depr(5y)143.13%
Cap/Sales(3y)13.98%
Cap/Sales(5y)15.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)165.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%662.69%
EPS Next Y54.78%
EPS Next 2Y40.28%
EPS Next 3Y34.65%
EPS Next 5Y44.34%
Revenue 1Y (TTM)34.39%
Revenue growth 3Y59.79%
Revenue growth 5Y60.72%
Sales Q2Q%26.28%
Revenue Next Year26.78%
Revenue Next 2Y24.39%
Revenue Next 3Y23.33%
Revenue Next 5Y18.91%
EBIT growth 1Y64.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73%
EBIT Next 3Y36.36%
EBIT Next 5Y28.5%
FCF growth 1Y111.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.89%
OCF growth 3YN/A
OCF growth 5YN/A

HIPPO HOLDINGS INC / HIPO FAQ

What is the fundamental rating for HIPO stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIPO.


What is the valuation status of HIPPO HOLDINGS INC (HIPO) stock?

ChartMill assigns a valuation rating of 4 / 10 to HIPPO HOLDINGS INC (HIPO). This can be considered as Fairly Valued.


What is the profitability of HIPO stock?

HIPPO HOLDINGS INC (HIPO) has a profitability rating of 1 / 10.


What are the PE and PB ratios of HIPPO HOLDINGS INC (HIPO) stock?

The Price/Earnings (PE) ratio for HIPPO HOLDINGS INC (HIPO) is 9.28 and the Price/Book (PB) ratio is 2.53.